46brooklyn, a nonprofit research group, appears to have significant financial connections to the pharmaceutical industry. Despite presenting its research as independent, it often aligns with the interests of drug manufacturers. The group's ties to Big Pharma are largely concealed, as it utilizes a for-profit consulting firm, 3 Axis Advisors, to funnel revenue and conduct research. This structure allows 46brooklyn to avoid detailed financial disclosures. The investigation reveals a network of shared leadership, funding, and research agendas between America's Agenda Healthcare Education Fund, 3 Axis Advisors, and 46brooklyn, all working to shift blame for high drug costs away from pharmaceutical companies and towards pharmacy benefit managers.
46brooklyn, the seemingly small nonprofit research operation, is entangled in a financial network leading to the top lobbying arm of the pharmaceutical industry. It has been planting what it presents as independent research, which often supports the policy goals of drug manufacturers, across the legacy media. The group’s ties to Big Pharma, however, are seldom disclosed by reporters.
Indeed, 3 Axis Advisors takes in considerable income, with much of it coming from organizations linked to the pharmaceutical industry. In 2023, the consulting firm partnered with America’s Agenda Healthcare Education Fund on a research project that cost well over $300,000,over $1 million in funding from Pharmaceutical Research and Manufacturers of America, better known as PhRMA, the primary trade association representing the interests of American drug manufacturers. PhRMA as one of its partners.
PHARMACEUTICAL INDUSTRY NONPROFIT RESEARCH LOBBYING FINANCIAL DISCLOSURES PHARMACY BENEFIT MANAGERS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Maximum bruiser for the money | Six of the BestBig power, big pace, big presence - big value
Read more »
FTC Report Shows Big Pharma Middlemen Jack Up Prices by Up to 7,736%Brett Wilkins is a staff writer for Common Dreams.
Read more »
Kennedy vows to end 'mass poisoning' of American children by Big PharmaRobert Kennedy Jr., President-elect Donald Trump's nominee for Health and Human Services Secretary, pledged to fight against pharmaceutical companies' influence during his confirmation hearing. Senator Tommy Tuberville praised Kennedy's focus on health, highlighting concerns about overprescribing ADD medication to minors and the impact of vaccines. Kennedy echoed these concerns, stating that U.S. leadership must prioritize scientific evidence over corporate interests.
Read more »
Kennedy Calls Out Sanders for Receiving Millions from Big PharmaRobert F. Kennedy Jr., President Donald Trump's nominee for Health and Human Services Secretary, accused Senator Bernie Sanders of hypocrisy during a Senate committee hearing. Kennedy pointed out that Sanders receives millions of dollars from the pharmaceutical industry while advocating for universal healthcare.
Read more »
RFK Jr. Accuses Sanders of Corruption Over Big Pharma TiesRobert F. Kennedy Jr., President Trump's nominee for Health and Human Services Secretary, criticized members of Congress, specifically Sen. Bernie Sanders, for accepting millions of dollars from the pharmaceutical industry. During a Senate hearing, Kennedy accused Sanders of protecting the interests of Big Pharma, prompting Sanders to deny receiving any corporate PAC money from the industry.
Read more »
Common Side Effects: A Trippy Animated Adventure Exploring Big Pharma's Dark SideCommon Side Effects, a new Adult Swim animated series, explores the consequences of a miraculous mushroom-based medicine. Follow two former high school lab partners as they navigate a world of corporate greed, government conspiracies, and international intrigue.
Read more »